Intra-Cellular Therapies Inc (NAS:ITCI)
$ 84.85 -1.15 (-1.34%) Market Cap: 9.12 Bil Enterprise Value: 8.05 Bil PE Ratio: 0 PB Ratio: 7.96 GF Score: 61/100

Intra-Cellular Therapies Inc (ITCI) Transcripts

  • 1